Insight
|
April 30, 2025
Interview with Dr. Armin Spura: BioDuro’s Recent Investment and Expansion Plan
In a recent conversation with Pharmaceutical Technology, BioDuro’s CEO, Dr. Armin Spura, discusses what differentiates our CDMO model, how our global footprint aligns with evolving regulatory landscapes, and the strategic investments shaping our future. The interview offers a high-level look at how BioDuro is redefining partnership and performance in drug development.
Watch the full video to learn how BioDuro is building the future of biopharma manufacturing—globally and with purpose.
Connect with a BioDuro team representative. Book a meeting with us.
PharmaTech article: https://www.pharmtech.com/view/bioduro-is-redefining-crdmo-partnerships-with-end-to-end-innovation
